Understanding Your Prescription Weight Loss Options
Mounjaro vs Ozempic vs Wegovy: Licensed Weight Management Treatments
When comparing Mounjaro vs Ozempic vs Wegovy, it's crucial to understand that Ozempic is not licensed for weight management in the UK and should not be considered for this purpose. Wegovy (semaglutide) and Mounjaro (tirzepatide) represent the two MHRA-approved prescription-only medicines specifically designed for weight management in adults. Wegovy works as a GLP-1 receptor agonist, mimicking your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro takes a dual-hormone approach, targeting both GLP-1 and GIP receptors simultaneously, though both require prescription assessment and ongoing medical supervision.
The comparison between Wegovy and Mounjaro isn't about which is "better" but rather which suits your individual medical profile and lifestyle requirements. Both treatments must be prescribed alongside a reduced-calorie diet and increased physical activity, and both are available through EverydayMeds following comprehensive clinical assessment. Your prescriber will consider factors including your BMI, existing health conditions, medication interactions, and personal preferences when determining the most appropriate treatment option for your weight management journey.
Wegovy Pricing Structure and Value Proposition
Wegovy's dose-escalation schedule offers transparent pricing from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from our FIRST40 discount code applied at checkout, whilst returning customers use DOSE25 for continued savings. Our Getting Started bundles provide convenient multi-dose packages, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, ensuring seamless transition between dose levels without supply interruptions.
The three-pen bundle options offer extended supply security, with the Intro Trio covering your first three months (0.25mg, 0.5mg & 1mg) for £299.99, whilst the Ultimate Stability Trio provides three months of maintenance dose (2.4mg ×3) for £649.99. These bundles prioritise convenience and Reliable Supply continuity rather than cost savings, ensuring you maintain consistent treatment without the need for frequent reordering. All pricing includes next-day cold-chain delivery and ongoing prescriber support through our GPhC-registered pharmacy.
Clinical Evidence Supporting Wegovy vs Mounjaro Effectiveness
The STEP trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management for eligible patients.
Mounjaro's clinical programme showed different results using different trial designs and patient populations, making direct comparison inappropriate. Both medications have demonstrated efficacy in their respective licensing studies, though individual responses vary significantly based on adherence, lifestyle modifications, and underlying health factors.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This hormone signals to your brain's appetite centres, promoting feelings of fullness and reducing food cravings throughout the day. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety after smaller meal portions. Wegovy also influences the brain's reward pathways, potentially reducing the appeal of high-calorie foods and snacking behaviours. This multi-faceted approach targets the complex biological mechanisms underlying appetite regulation and weight management, though results require consistent use alongside dietary and exercise modifications.
Streamlined Ordering Process at EverydayMeds
Beginning your Wegovy journey requires just a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review all applications within 3 working days (24 hours with express review), ensuring thorough evaluation of your suitability for treatment. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled packaging to maintain the cold-chain integrity essential for Wegovy's stability. Our pharmacy team coordinates timing to ensure you receive your medication promptly whilst maintaining the highest standards of pharmaceutical care. The entire process operates under our GPhC registration #9012878, guaranteeing regulatory compliance and patient safety throughout your treatment journey.
Storage Advantages and Practical Considerations
Wegovy offers significant practical advantages in storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability window proves invaluable for travel, work schedules, and lifestyle flexibility without compromising medication effectiveness. The FlexTouch pen delivery system provides intuitive dose administration with clear visual confirmation and audible click confirmation of injection completion. Wegovy's mandatory dose escalation schedule (0.25mg→0.5mg→1mg→1.7mg→2.4mg) occurs over 16 weeks, allowing gradual tolerance development and side effect minimisation. Each pen contains four weekly doses, simplifying medication management whilst the once-weekly injection schedule fits seamlessly into most lifestyle routines.
Comparing Mounjaro vs Ozempic vs Wegovy: Treatment Selection Factors
When evaluating Mounjaro vs Ozempic vs Wegovy for weight management, only Wegovy and Mounjaro should be considered as they hold specific MHRA licensing for this indication. Wegovy's single-hormone approach may suit individuals seeking established GLP-1 therapy with extensive clinical data and flexible storage requirements. The medication's cardiovascular outcome data from the SELECT trial adds value for patients with existing heart disease risk factors.
Mounjaro's dual GIP/GLP-1 receptor activation represents a newer therapeutic approach that some patients may find more effective, though this varies significantly between individuals. Both treatments require identical lifestyle commitments including reduced-calorie diet and increased physical activity, making medication selection just one component of comprehensive weight management strategy.
Starting Your Prescription Weight Loss Journey
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your medical profile and personal circumstances. Our clinical team evaluates factors including previous weight management attempts, current health conditions, medication interactions, and lifestyle requirements when recommending treatment options. Use discount code FIRST40 for new customers or DOSE25 for returning customers to access our competitive pricing structure across all dose levels and bundle options. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards medically-supervised weight management. Our comprehensive approach ensures you receive not just medication supply, but ongoing support and guidance throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
